France · Delayed Price · Currency is EUR Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 90.48 billion. The enterprise value is 108.06 billion.
| Market Cap | 90.48B |
| Enterprise Value | 108.06B |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | May 5, 2026 |
Share Statistics
Sanofi has 1.20 billion shares outstanding. The number of shares has decreased by -2.54% in one year.
| Current Share Class | 1.20B |
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | -2.54% |
| Shares Change (QoQ) | -0.63% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 44.27% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 23.25 and the forward PE ratio is 8.56. Sanofi's PEG ratio is 1.08.
| PE Ratio | 23.25 |
| Forward PE | 8.56 |
| PS Ratio | 1.85 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 10.14 |
| P/FCF Ratio | 9.01 |
| P/OCF Ratio | 7.64 |
| PEG Ratio | 1.08 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.96, with an EV/FCF ratio of 10.76.
| EV / Earnings | 27.30 |
| EV / Sales | 2.21 |
| EV / EBITDA | 7.96 |
| EV / EBIT | 10.69 |
| EV / FCF | 10.76 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.34.
| Current Ratio | 0.99 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 2.35 |
| Interest Coverage | 17.08 |
Financial Efficiency
Return on equity (ROE) is 5.71% and return on invested capital (ROIC) is 9.12%.
| Return on Equity (ROE) | 5.71% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 9.12% |
| Return on Capital Employed (ROCE) | 10.66% |
| Weighted Average Cost of Capital (WACC) | 4.99% |
| Revenue Per Employee | 653,595 |
| Profits Per Employee | 52,882 |
| Employee Count | 74,846 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.25 |
Taxes
In the past 12 months, Sanofi has paid 1.20 billion in taxes.
| Income Tax | 1.20B |
| Effective Tax Rate | 23.16% |
Stock Price Statistics
The stock price has decreased by -9.21% in the last 52 weeks. The beta is 0.28, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -9.21% |
| 50-Day Moving Average | 75.59 |
| 200-Day Moving Average | 79.33 |
| Relative Strength Index (RSI) | 49.21 |
| Average Volume (20 Days) | 2,186,628 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 48.92 billion and earned 3.96 billion in profits. Earnings per share was 3.26.
| Revenue | 48.92B |
| Gross Profit | 35.93B |
| Operating Income | 10.35B |
| Pretax Income | 5.20B |
| Net Income | 3.96B |
| EBITDA | 13.54B |
| EBIT | 10.35B |
| Earnings Per Share (EPS) | 3.26 |
Balance Sheet
The company has 6.35 billion in cash and 23.58 billion in debt, with a net cash position of -17.23 billion or -14.38 per share.
| Cash & Cash Equivalents | 6.35B |
| Total Debt | 23.58B |
| Net Cash | -17.23B |
| Net Cash Per Share | -14.38 |
| Equity (Book Value) | 69.57B |
| Book Value Per Share | 57.77 |
| Working Capital | -408.00M |
Cash Flow
In the last 12 months, operating cash flow was 11.84 billion and capital expenditures -1.80 billion, giving a free cash flow of 10.04 billion.
| Operating Cash Flow | 11.84B |
| Capital Expenditures | -1.80B |
| Depreciation & Amortization | 3.19B |
| Net Borrowing | -221.00M |
| Free Cash Flow | 10.04B |
| FCF Per Share | 8.38 |
Margins
Gross margin is 73.45%, with operating and profit margins of 21.16% and 8.09%.
| Gross Margin | 73.45% |
| Operating Margin | 21.16% |
| Pretax Margin | 10.62% |
| Profit Margin | 8.09% |
| EBITDA Margin | 27.68% |
| EBIT Margin | 21.16% |
| FCF Margin | 20.52% |
Dividends & Yields
This stock pays an annual dividend of 4.12, which amounts to a dividend yield of 5.39%.
| Dividend Per Share | 4.12 |
| Dividend Yield | 5.39% |
| Dividend Growth (YoY) | 5.10% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 124.38% |
| Buyback Yield | 2.54% |
| Shareholder Yield | 7.93% |
| Earnings Yield | 4.37% |
| FCF Yield | 11.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sanofi is 94.28, which is 24.84% higher than the current price. The consensus rating is "Buy".
| Price Target | 94.28 |
| Price Target Difference | 24.84% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 4.39% |
| EPS Growth Forecast (3Y) | 8.12% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |